Monday, 16 December 2013

Saxagliptin (Onglyza®) 2.5 mg and 5 mg film-coated tablets

Saxagliptin (Onglyza®) is recommended as an option for use within NHS Wales for the treatment of adult patients aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control as triple oral therapy in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control (All Wales Medicines Strategy Group)

No comments:

Post a Comment